Tag: Mike Wise Show

Dr. Ethan Russo is a world-renowned authority on the medicinal use of cannabis; an academic researcher, author and industry leader whose expansive knowledge of cannabis therapeutics spans history, cultures and its myriad applications for improved health and wellbeing. A board-certified neurologist and former Senior Medical Advisor at GW Pharmaceutics, Dr. Russo is currently Director of Research and Development of the International Cannabis and Cannabinoids Institute, a consortium of international academic institutions and private companies dedicated to promoting medical cannabis research.

In this interview, Dr. Russo shares an informed and insightful vision of how cannabis-derived medicine stands to benefit two of the more intractable neurological conditions facing older adults, Parkinson’s (PD) and Alzheimer’s (AD) diseases.

Abbie Rosner: If medicinal cannabis targets our endocannabinoid system (ECS), what is the involvement of that system in PD and AD?

Dr. Ethan Russo: The ECS regulates most physiological systems in the body, but above all the nervous system, where it helps to achieve the balance that allows individual nerve cells to communicate. The ECS is disrupted in both AD and PD.

Rosner: What is the research with cannabinoids and Parkinson’s disease showing?

Russo: In a mouse model of PD, treatment with nabiximols (Sativex®), a cannabis- based pharmaceutical approved in 30 countries outside the USA, resulted in improvement in dopamine neurotransmitter function, and reduced oxidative stress (akin to “rust” of the nervous system), as well as leading to improvements in anxiety and self-injury behaviors.

Clinical results with treatment of PD with cannabis have been quite mixed. Cannabidiol (CBD) helped a few PD patients with psychotic symptoms, and some with a rapid-eye movement sleep disorder. Observational studies with smoked cannabis, presumably high in THC, reportedly produced acute benefits on tremor, rigidity and slow movement (bradykinesia). The best results in PD were reported in a Czech study in 2004, in which patients ate raw leaves of cannabis for as much as three months and reported significant improvement in overall function, tremor, bradykinesia and rigidity, with few side effects.

Rosner: And what about cannabis for AD?

Russo: The story in AD is even more intriguing. Both THC and CBD have been shown to interfere with the production of abnormal toxic matter in the brain of such patients. This is quite exciting, inasmuch as synthetic drugs designed for similar purposes have yet to advance in the clinic. Both THC and particularly CBD are known neuroprotective agents that hold the potential to slow or perhaps even halt the degenerative process. On the symptom side, THC as a single agent has proven beneficial in AD patients in reducing nocturnal agitation, improving sleep and appetite. Observations of nursing home patients in California with dementia have produced similar benefits as well as reducing the need for nursing intervention and amounts of other drugs.

There are four FDA-approved pharmaceuticals to treat memory loss in AD, but all have mild benefits on a temporary basis. These are designed to increase the amount of acetylcholine, the memory molecule in the brain that becomes depleted in AD. Interestingly, the terpenoid alpha-pinene is capable of boosting acetylcholine by inhibiting its breakdown, and with fewer side effects than the conventional drugs.

Rosner: We hear a lot of talk about THC and CBD, but what about the role of terpenes?

Russo: Terpenes are aromatic compounds from plants that are important in our everyday exposure to scents and flavors. Some of these, when combined with cannabinoids, boost their effects such that the result is greater than the sum of the parts. We discussed above the role of alpha-pinene to combat memory deficits in AD and PD. Linalool, a component of lavender essential oil as well as cannabis, has been demonstrated to calm agitation in AD. The terpene limonene, common to citrus and cannabis, is a powerful antidepressant and immune stimulator. Caryophyllene, a terpenoid with the distinction of also being a cannabinoid, is of key importance in AD, as it may help in clearance of beta-amyloid waste in the brain.

Rosner: CBD products are so popular now. But what price is paid when you remove THC from the cannabis equation?

Russo: A severe price may be paid if cannabis-based medicines are devoid of THC. It is clear from the above that THC has a major role to play in both symptomatic treatment of dementia and quite possibly in preventative benefit. The dangers of THC have been vastly exaggerated by alarmist politicians and the press, particularly in such contexts where alternatives have been extremely disappointing and are actually much more problematic. Very small doses of THC are required and their benefits outweigh any risks by healthy measures.

Rosner: You have also been a proponent of diet and other complementary approaches to cannabis.

Russo: Fascinating epidemiological studies have linked diet to degenerative diseases, especially AD. Diabetes and obesity, which are rampant in the USA, as well as trans-fats, all increase AD risk. In contrast, disease rates are lower in areas following a Mediterranean diet rich in monounsaturated olive oil and omega-3 fats from fish. We also know that daily cognitive challenges when carried into the elder years offer some protection, as does vigorous physical exercise.

An underappreciated factor in degenerative diseases is the microbiome, the bacterial content of the gut. We know that THC, rather than leading to obesity as one might surmise, rather changes the microbiome balance in the gut to favor bacteria that protect from development of obesity and the metabolic syndrome.

Great benefits may accrue to AD and PD patients through the use of probiotics (i.e., natural organic multi-culture yogurt, kefir, lacto-fermented vegetables, and supplements in capsules) and prebiotics (vegetable matter like acacia fiber, slippery elm, burdock root and supplement in capsules) that provide an optimum feedstock for the beneficial gut bacteria.

Rosner: From where we are today, what are the best approaches for prevention and treatment of PD and AD?

Russo: The best current approaches to AD and PD beyond what the conventional pharmacopoeia offers include: aerobic activity, daily mental exercise, Mediterranean diets with use of anti-inflammatory fruits and berries, probiotics and prebiotics. From cannabis, THC, THCA, CBD, beta-pinene, caryophyllene, linalool and limonene may all have important contributions to treatment of these disorders.

Rosner: Where do you see promise on the horizon?

Russo: While the current laboratory experiments have been extremely important in establishing a foundation for cannabis-based medicines in treatment of AD and PD, it is definitely time to move the effort into the clinical arena. It is clear that these conditions are increasing in our aging populations and conventional approaches to date have been less than satisfactory. Utilization of cannabis preparations with the right mixtures of cannabinoids and terpenoids show great promise to produce better results. While these may be simply palliative in reducing drug and care burdens, there is also the possibility of making a real difference in slowing or abrogating the pathological processes in these two disorders.

The conversation has been edited and condensed for clarity.


Originally published at: https://www.forbes.com/sites/abbierosner/2019/02/26/cannabis-for-parkinsons-and-alzheimers-diseases-an-interview-with-dr-ethan-russo/?fbclid=IwAR03BkSPfWjBzEJCRLxWv8p9yKpu7jj_M2R0rs6jXTDbxWKg7mK32m7sGqQ#3b31b7b95dd6

‘When you call police to say, ‘Come look at this,’ you believe you have everything in order’

Tweed Marijuana Inc. became the first publicly traded medical pot company in Canada on Friday, but behind the scenes the Ontario production facility has apparently been searching for answers after a run-in with the law.

On Monday, the company was hoping to beef up its stock with a shipment of medical marijuana products that it says it acquired from B.C. growers who had previously been licensed to grow their marijuana at home.

Even though the company had received Health Canada’s approval to import such products, the Mounties, who the company said it had invited to inspect the shipment, ended up seizing it at the Kelowna International Airport.

“We felt everything was done absolutely correctly,” Tweed chairman Bruce Linton said from the company’s office in Smiths Falls. “When you call police to say, ‘Come look at this,’ you believe you have everything in order.”

The case seems to highlight an ongoing confusion around the old legal regime, which allowed licensees to grow medical pot in their basements, and the new regime, which restricts production to commercial growers, such as Tweed.

As of Friday, the company — one of 12 licensed so far in Canada — had still not received an explanation for the seizure, Linton said.

Sgt. Duncan Pound, an RCMP spokesman in B.C., refused to comment on the reasons for the seizure.

“We typically do not confirm or deny investigations unless there is an investigational or public safety need. Specific details about any investigation only become known when that investigation results in charges being laid by Crown Counsel,” he said via email.

Before the April 1 switch to the new regulatory regime, individuals who previously had personal-production licenses were allowed to sell what “starting materials” they had, such as seeds and plants, to one of the new commercial producers.

Linton said Friday his company hadn’t originally intended to purchase other medical marijuana products; the initial business plan was to grow about 25 varieties of plant at the company’s 160,000-square-foot growing facility.

But when the company started accepting customers early in February, demand for its products proved much higher than expected, Linton said.

It became clear, he said, that the amounts sought per patient were “several multiples” higher than what the company had planned for. When Tweed pointed this out to Health Canada officials, the company was told that other commercial growers were buying medical pot from growers who had been licensed under the old regime.

The only stipulation was that they needed federal authorization to do so.

Health Canada spokeswoman Sara Lauer confirmed Friday that Tweed received the go-ahead.

Linton said the company collected plants, seeds and “in-production plant materials” from multiple growers across B.C. He declined to say exactly how much product was acquired, but said it provided the firm with an additional 55 varieties of marijuana.

Linton said the company’s purchases from B.C. were a one-time thing and that all future product will be grown in Smiths Falls.

The company invited the RCMP to come inspect the shipment at the Kelowna airport Monday, the last day such transactions could take place.

“Our intent was to be transparent,” he said. Plus, having the Mounties around also provided extra security for the precious cargo.

Health Canada officials were unable to say Friday how many other commercial growers had acquired marijuana products from home growers before the deadline.

Linton speculated that the RCMP seizure may have been the result of “confusion” because of overlapping regulations.

Last month, a Federal Court judge granted an injunction for medical marijuana users who had previously held a personal-production license.

The injunction allowed those users to continue growing pot until the court issues a final decision.

On Monday, the same day the Tweed shipment was seized, the federal government announced it was appealing the court ruling.

The closing price for shares in Tweed Marijuana Inc. on Friday was $2.59 on the TSX Venture exchange, valuing the company at $90.7 million (market capitalization).

Originally published at: https://nationalpost.com/news/canada/canadas-first-publicly-traded-marijuana-company-has-rough-first-day-when-pot-shipment-seized-by-rcmp?fbclid=IwAR0v5x3fCJJPCbNW7QUoDhmNBtXTt_6og0E_KKPAWplUXzJZq5Wj-AyyR_U

You may not be aware of it, but alcohol damages the brain as soon as its effects can be felt. That’s right, bad decision making and memory blackouts are direct effects of alcohol-induced brain damage. Scary, huh?

The science surrounding the damaging effects of alcohol is very clear. In fact, there is no safe level of alcohol consumption and any amount of alcohol raises your risk of cancer.

Would you believe that alcohol is actually rated as more damaging than heroin in harm indexes?

Despite these facts, alcohol is legal and widely available in the UK. Us Brits even get drunk on alcohol more than any other nation. 

Recent research from the University of Colorado in Boulder, however, has found evidence that suggests cannabinoids are far safer for long-term brain health compared to alcohol.

Cannabis is safer than alcohol

For many years, we have been told by our government that cannabis will damage our bodies and brains and turn us crazy. Propaganda in the 90s showed a fried egg to demonstrate what would happen to your brain ‘on cannabis’.

It turns out that nothing could be further from the truth. 

Reefer madness 

Now, thanks to the Internet and a relaxing of prohibition in some parts of the world, the science of cannabis is exploding and facts can no longer be hidden or smeared by the government.

In fact, this latest research goes some way to prove that most propaganda is completely untrue. The final conclusions of this study sum it up nicely:

“Marijuana and associated cannabinoid products…were not shown to have any long-term impact on the amount of gray matter in the brain or on the integrity of the white matter.”

But the truth is even more interesting than ‘no damage’.

Cannabis is good for the brain!

Research from 2018 has shown that cannabis use can have positive long term effects on the brain

This study, led by Staci Gruber, found that after just three months of cannabis treatment, participants were able to perform tasks better and had improved activation at two different cortexes of the brain which are responsible for controlling parts of our emotions and memories. 

While that study is ongoing and is set to finish in around 24 months time, these results concur with studies coming out of Israel that show cannabis can prevent the brain from ‘slowing down’ as we age.

It is clear we are only beginning to scratch the surface of the benefits to humanity of this powerful and controversial plant. However, there is little doubt that people would be much healthier should they chose to consume cannabis over alcohol.

Originally published at: https://www.highandpolite.co.uk/cbdnews/alcohol-destroys-the-brain-cannabis-heals-it-says-latest-science?fbclid=IwAR0uJGHhhuMIHyxAb9l7tJRflG6HhB2PR_kZeHJl0dVv9PAv7sYaQwMecRo

Hemp fibers are naturally stiff and ropy, but Levi’s has discovered a way to make it feel like cotton.

• Denim icon Levi Strauss & Co. debuted garments made from a soft hemp-cotton blend in March, and head of innovation Paul Dillinger said he expects 100% cottonized-hemp products in about five years.
• Hemp uses significantly less water and chemicals than cotton during cultivation. Levi’s has found a way to soften hemp using far less water than was previously used.
• Dillinger said the long-term goal is to incorporate sustainable cotton blends by using fibers such as hemp into all of its products.

With the legalization of hemp in the United States last December, the industry has been exploding: Reports and Data estimates it’ll be worth $13.03 billion by 2026. While you’ve probably noticed hemp-derived CBD products everywhere, hemp also has major implications for sustainable clothing — and denim icon Levi Strauss & Co. has made significant progress in making this happen.

In March, Levi’s debuted a collaboration with the Outerknown label that includes a pair of jeans and jacket made from a 69%-cotton/31%-hemp blend that feels like pure cotton. Why’s that significant? Hemp, a cannabis plant with a negligible amount of the psychoactive chemical THC, uses significantly less water and chemicals than cotton. Unlike cotton, though, the material is difficult to work with. The cotton fibers in your shirt are derived from a puffy bud on top of a plant, while hemp fibers come from a tall, sturdy trunk.

“It’s a longer, stiffer, coarser fiber,” Levi’s head of global product innovation, Paul Dillinger, told Business Insider. “It doesn’t want to be turned into something soft. It wants to be turned into rope.” Levi’s has found a way to make hemp fibers soft and able to blend with cotton, but in a way that uses significantly less water than the process used to turn hemp plants into a rough material. “It’s great that it’s resonating with the consumer, but it’s more important that it’s helping to future-proof our supply chain,” he said.

Dillinger explained that this is a significant research project that will continue for years, rather than a project that only results in a couple of high-end, niche products. “Our intention is to take this to the core of the line, to blend it into the line, to make this a part of the Levi’s portfolio,” he said.

Dillinger said Levi’s is continuing to work on improving the quality of its cottonized-hemp, to the point where it can be nearly half of a cotton-blend for most apparel, as well as fully hemp for certain products. And in five years, he said, he expects “a 100% cottonized-hemp garment that is all hemp and feels all cotton.”

Dillinger said that the need for cotton alternatives became apparent when looking at the growth trajectory of cotton demand compared to access to fresh water required for its cultivation and processing. Since he was familiar with the nature of hemp, he did not expect to find a solution there… until Levi’s discovered cutting-edge research in Europe, where industrial hemp was already legal in many countries. Levi’s would not reveal its partners or details of its breakthroughs, except to say that it had a market-ready material after three years.

When Levi’s finds a way to make 100% cottonized-hemp clothing, “We’re going to go from a garment that goes from 3,781 L of fresh water, 2,655 of that in just the fiber cultivation,” Dillinger said, drawing from data collected by the Stockholm Environmental Institute. “We take out more than 2/3 of the total water impact to the garment. That’s saving a lot.”

Despite his optimism, Dillinger was quick to point out that he doesn’t want hype around the hemp industry to make it seem like Levi’s and its competitors are going to fully replace cotton or revolutionize the industry overnight. To do it properly, there remains many years of research and development. Plus, it’s likely hemp will be just one of several natural cotton alternatives.

The idea is that hemp clothing, whether in a cotton blend or by itself, isn’t going to be a fad. Dillinger said that while he can’t speak for the company on this point, he personally isn’t too concerned about the marketing of cottonized-hemp clothing, because the ideal down the line is that customers won’t even notice a difference.

“So often there’s the assumption that to purchase a sustainably-made product is going to involve a sacrifice, and that the choice is between something ethically made or something that’s cute,” he said. “You don’t have to sacrifice to buy sustainably.”

There were also concerns the release of information could embarrass Health Canada and expose ‘deficiencies’ in new medical marijuana regulations

In the spring of 2014, RCMP officers in Kelowna, B.C. prepared a press release about a big drug bust at the local airport. It described how investigators had intercepted two shipments of marijuana of “unfathomable quantity” that were bound for a couple of licensed cannabis producers in Ontario. The press release, however, was never sent.

Days went by with a virtual information blackout over what the Mounties had seized and why, even after one of the companies — Tweed Marijuana Inc., now Canopy Growth Corp. — decided to release its own public statement, containing what some RCMP members perceived to be “brutally misleading” information about the seizure.

“I don’t see how we can’t comment as we are now being put in a negative light,” one frustrated sergeant wrote to a colleague in an email. “Basic media principles state that we should confirm the obvious — Tweed has chosen to put this out there so we would be remiss if we did not comment on factual points that have been inaccurately represented.”

More than 900 pages of internal records obtained by the National Post reveal for the first time the lengthy deliberations that took place among RCMP members in B.C. and at RCMP headquarters in Ottawa over what, if anything, to tell the public about the March 31, 2014, seizures at Kelowna International Airport.

Among the “strategic considerations” outlined in emails was a concern that the release of information might affect the stock price of Tweed, which had gone public on the Toronto Stock Exchange that week — the first pot producer in the country to do so. There were also concerns that the release of information could embarrass Health Canada and expose “deficiencies” in new regulations over medical marijuana production that were rolling out that same week.

The National Post first sought access to the records five years ago through an access-to-information request. The RCMP initially refused to release any records, citing an ongoing investigation. The Post complained to the federal information commissioner, resulting in a process that dragged on until last fall when the RCMP finally agreed to process some of the records.

Asked this week about the national police force’s apparent concern over the impact of publicity about the bust on the company’s stock price and the potential political embarrassment to the federal government, B.C. RCMP spokeswoman Sgt. Janelle Shoihet said she needed more time to review the file. “Generally we can say that decisions with regards to communications will always consider impact on prosecution, timing and whether (or) not a company is publicly traded. These factors have been considered in the past and were not unique to this investigation,” she wrote.

“Impacts on partners, disclosure, potential or active prosecutions and privacy legislation must all be considered when determining what, if any, information can be made public.”

But Garry Clement, a retired RCMP superintendent, said whether a company is publicly traded or not should not have been a consideration.

“When you see something like that, how can you say the RCMP is being objective? They’re playing in the hands of the company. Investors may have made a decision differently had they known the facts, he said. “It doesn’t give the impression of being upfront.”

In September 2015, Tweed was renamed Canopy Growth Corp. Jordan Sinclair, Canopy Growth’s vice-president of communications, said in an email this week the seizures happened more than five years ago when the Marijuana for Medical Purposes Regulations were in their infancy.

“The company believed then and now that it acted in compliance with regulations. Today, we are focused on the next five years and continuing to build a global cannabis leader creating thousands of jobs in Canada, investing hundreds of millions of dollars into the Canadian economy, and providing the highest quality cannabis products to medical and adult-use customers around the world.”

Mettrum Health Corp, the other Ontario producer whose shipment was seized that day, was acquired by Canopy Growth in early 2017. A former spokesman for Mettrum did not respond to an email requesting comment.

The seizures happened against a backdrop of dramatic change in Canada’s regulatory landscape. New rules took effect on April 1, 2014 that restricted production of medical marijuana to licensed commercial producers. Tweed and Mettrum were among the first to be licensed.

Prior to the transition date, individuals who had possessed personal-production licenses under the old regime were able to sell their starting materials — namely seeds and plants — to one of the new commercial producers, as long as they had Health Canada approval. Tweed and Mettrum received those approvals, Health Canada confirmed to reporters at the time.

But according to internal RCMP briefing notes, the items Tweed and Mettrum told Health Canada they would be importing from B.C. did not match what was seized at the Kelowna airport on March 31.

On paper, Tweed and Mettrum said they planned to transport 2,071 plants and 730 plants, respectively. But when RCMP examined the shipments, they instead found harvested marijuana buds that were packaged for resale, the records say.

“It was packaged bud that was seized, which is materially different from ‘plants and seeds,’” one RCMP investigator wrote.

“At best what has been seized are clippings,” a summary report stated. “The (regulations) do not allow for the sale of marijuana in this form.”

And there was a lot of it — more than 700 kilograms of B.C. bud stored in 55 hockey bags and 40 boxes.

A draft press release prepared by the Kelowna RCMP’s media relations officer on April 1 noted that the seizure was of a quantity “rarely seen in the central Okanagan.”

“Several local growers had pooled their products for transfer … but the shipment fell outside the parameters of the legislation and was subsequently seized by police,” it said, adding that the size of the shipments was enough to create 2.1 million single doses based on 0.3 gram cigarettes.

But senior officers, including the Kelowna detachment’s commanding officer, decided to hold off on the release, citing the lack of any charges.

A couple days later, on April 3 — the day before Tweed was listed on the TSX Venture Exchange — the company put out its own statement. Tweed said it had completed the acquisition of “seeds and plants” from a number of licensed growers, ensuring a “wide variety of choices” and sufficient inventory to meet demand.

The company acknowledged that one shipment had been held by the RCMP “while it confirms the details of the shipment.”

“In an effort to be transparent,” the statement continued, the RCMP was informed of the shipment and “invited to examine the material.”

Tweed chairman Bruce Linton told Postmedia at the time the seizures may have been the result of “confusion” over the old and new regulatory regimes.

“When you call police to say, ‘Come look at this,’ you believe you have everything in order,” he said.

In internal emails, RCMP officers wrote that it was “painful” to not be able to respond and that the company’s version of events was “a long way from what transpired.”

“I find their language very interesting/misleading considering there were no ‘plants,’ ‘seeds,’ or ‘in-production material,’” Const. Kris Clark, Kelowna’s media officer, wrote to colleagues.

Officers also balked at the company’s assertion that it had invited the RCMP to inspect the shipment. Briefing notes indicate that in the week prior to the seizures, RCMP received “several calls” from airline charter companies enquiring about the “legitimacy of transporting 1500 lbs of marijuana.”

“Tweed never came to us, the airline did,” Const. Shane Holmquist wrote to colleagues.

Insp. John Ibbotson told a colleague in an email that although the company’s statement may appear to be a standard press release, “it is in fact a news release intended to inform investors of a publicly traded company of a significant event surrounding a company’s activity.”

Noting that some of the information in Tweed’s release was “factually incorrect,” Ibbotson suggested there had been a violation of section 400 of the Criminal Code — related to making a false prospectus — and wondered if the Ontario Securities commission should be notified.

Yet for several more days, RCMP communications officers declined to set the record straight, trotting out the standard line that they could not confirm nor deny an investigation.

“With some luck the media may dig up the facts and print them without the RCMP having to go public with any details and face the complications that would create,” Sgt. Duncan Pound, then a federal policing spokesman in B.C., wrote to a colleague.

Other emails reveal some of the reasons for the hesitation.

“The heart of the problem is that Health Canada has gone on record as saying they authorized the shipment, which has and will continue to cause us grief trying to set the record straight,” Pound wrote.

“Ideally,” he continued, Health Canada should issue a statement saying the shipments contravened regulations and were not what they had authorized. “If Health Canada says nothing it looks like two Ministries working against each other, which is a lose/lose for both of us.”

Jolene Bradley, the RCMP’s director of strategic communications in Ottawa, presented a briefing document to the deputy commissioner for federal policing on April 10 advising that the force should continue to decline comment. Among the reasons she cited: going public “would likely bring criticism on Health Canada’s part as it would highlight the deficiencies in the transition to the new regulations.”

The same document also stated that “any comments by the RCMP could impact stock prices” for the producers.

Dawn Roberts, an RCMP communications strategist in B.C., similarly wrote in an email to colleagues that Tweed “is a publicly traded company and any comments could impact on stock prices.”

Pressure, however, was starting to build “from higher up to proactively correct the story,” RCMP emails say.

The force eventually issued its first public statement about the March 31 seizures on April 11. But the press release was whittled down considerably from a draft version. The draft included the size of the seizure (705 kilograms) and the reason: regulations allowed for a pre-determined number of plants to be sold, but the shipments consisted of “harvested marijuana in lieu of plants.”

The final version of the statement did not mention the size of the seizure nor the specific reason, simply stating: “The marijuana did not match what was authorized to be transferred.”

No charges were ultimately filed against either company due to the challenge of proving criminal intent, RCMP briefing notes say. The seized marijuana, which caused a rotting smell in RCMP storage, was later destroyed.

Douglas Quan
May 31, 2019
7:00 AM EDT

Originally published at: https://nationalpost.com/news/canada/rcmp-went-silent-about-massive-pot-bust-over-concern-for-marijuana-producers-stock-price-documents-reveal?fbclid=IwAR0CqxQqG8ebHpXeZG9vzdkhW5A1nt0qQI4JCaDAhSGBfE-_Doa8wO0_u6k

The use of cannabis is a very controversial topic in the medical community. Some well-respected doctors say that it should be used in some treatments and other doctors are against it and are concerned about its long term effects. The next case is a proof that that the first group of doctors were right.

Jayden David was perfectly born child. He didn’t have any problems at all, but at only four mounts old he began having seizures. Sometimes he had up to 500 seizures a day. Imagine how he felt and how his family felt seeing this little innocent boy struggle every day. Sometimes he even waked up in the middle of the night crying and screaming from pain and hallucinating. That’s why they did everything to help him.

Jayden and his father visited a lot of doctors and had a lot of consultations and one day his dad decided that this torture needs to stop. With a consultation with some well-respected doctors he decided to try helping his son with medical marijuana.

Jason David was willing to try anything to save and help his son get through his pain. He didn’t have more money and the insurance companies weren’t helpful.

The same day they started using cannabis oil there were visible results. It was the first day after 5 years that Jayden didn’t have any seizure at all. Days passed and Jayden was all cheered up and his father could have seen the relief in his eyes.

Jayden started swimming. Before that, any temperature change would have caused seizure, but this time Jayden was all happy playing in the water. He even started chewing his food.

This little boy was taking really strong medications that weren’t recommended for 5 year old boys and his father took him off of them when he discovered the cannabis oil.

Originally published at: https://medium.com/@ahealthycrew/cannabis-oil-replaces-22-pills-for-little-boy-with-seizures-d0b22ea6be09

After a landslide vote of 101-11 this week in the Florida House SB 182 gets signed into law today by Governor Ron DeSantis at 2:40 PM

Gary Stein of Clarity PAC and other sources in Tallahassee, confirmed that Florida Governor Ron DeSantis signed SB 182 into law today at 2:40PM. This can be confirmed according to a Florida 1st District Court of Appeals filing, Govoner Ron DeSantis has signed SB 182 into law. The repeal of the smoking ban on medical marijuana is now official.

                    From the 1st District Court of Appeals

Earlier this year DeSantis put a deadline on this process himself by pressuring the legislature into establishing legal verbiage by March 15, the start of the legislative session. SB 182 will be the first bill of this session to be reviewed at the Governor’s desk.

This bill not only repeals the smoking ban that had been deadlocked by a state appeal, but it also allows doctors to order a 210-day supply of medical cannabis (opposed to the current 70-day limit). Other stipulations include submitting oneself for a data study on the effects of smoking marijuana, but also requires minors (under the age of 18) to be diagnosed with a terminal condition and get a second opinion from their primary pediatrician (or a secondary pediatrician) before receiving the prescription.

DeSantis commended the Legislature for their efforts via Twitter saying, “I thank the Florida Legislature for taking action on medical marijuana and upholding the will of the voters”, but until this signing had not released a formal statement. Having only 3 months in office, his administration is moving at a record pace.

House Speaker Jose Oliva commented after the vote earlier this week, “This is a difficult issue, and you’re going to have people on both sides; some that are happy that now this is available to them and others that feel that we didn’t go far enough,” adding “We did the best that we could do and still remain responsible.”

Rep. Ray Rodrigues was still not convinced, warning doctors with these remarks, “What I would say to the medical community is that it is incumbent upon them to do their jobs to treat this as medicine … The last thing we want to see is the pill mill crisis that occurred with opioids to occurring in this state with medical marijuana. So we’ll be watching.”

Stern words, although laden with traditional rhetoric, likening cannabis to opioids and implying that people are likely abusing the substance and questioning its medical validity. It is unfortunate that these sentiments are still so common when more and more medical research is being conducted showing the immense healing properties associated with cannabis in a multitude of different ailments. Advocates are encouraged to reach out to representatives with testimonials and personal experiences with cannabis in an effort to remove the stigma placed on the canna-community.

Nikki Fried, another new contender in the Florida political landscape and current Agricultural Commissioner, mentioned after the vote, “Today’s action to finally allow smokable medical marijuana brings four words to the lips of people across our state: It’s about damn time.” Fried not mincing any words also stated, “It’s long past due that the State of Florida honored the will of the people and allowed doctors to determine their patient’s course of treatment.”

Not only are lawmakers and advocates ready to welcome this new wave of products to patients, they are also excited about the possibility of bringing more jobs and increasing Florida’s agricultural potential.

Many advocates and patients are saying this is only the beginning, noting that HB 1117 has already been filed to legalize recreational, or responsible adult-use cannabis, although it has not received a hearing thus far. The bill was filed by Rep. Carlos Guillermo Smith, who also raised issues regarding affordability and law enforcement training, specifically so that legitimate patients aren’t harassed or arrested.

Now that smokable whole-flower cannabis has been approved by the Governor, law enforcement’s ability to make a distinction between medical cannabis and black market cannabis is more pertinent than ever. He says law enforcement needs real-time access to the medical marijuana registry so that patients will be treated as though they have any other prescription medication.

“My hope is that with the legislation that law enforcement will train themselves,” noted Smith. “Because even the wrapped product, the wrapped whole flower product can leave a scent behind in the car which can leave a scent mistaken as smoked medical cannabis.”

Many dispensaries throughout the State including the largest distributor, Trulieve, have already stated that they are ready to roll out new product immediately and that they have been waiting for this repeal for quite some time. Jennifer Houghtaling, the manager of the Saint Petersburg Trulieve dispensary was quoted saying, “We’re waiting on the Department of Health to give the go-ahead and we’re prepared, we’re ready, and we just cannot wait. We know how beneficial it is to be able to smoke the plant. We’re very excited, and our patients are as well.”

The wait is over, and patients are ready to explore many more treatment options and possibilities.

source: 
Gary Stein of Clarity PAC and other sources in Tallahassee